| Literature DB >> 34984442 |
Xin Li1,2, Jacky Man Chun Chan3, Bosco Lam4, David Christopher Lung5,6, Kwok Cheung Lung7, Christina Kin Yi Chow5, Tracey Tam8, Kelvin Hei Yeung Chiu2, Ling Lung Hung2, Ivan Fan Ngai Hung9, Vincent Chi Chung Cheng2, Kelvin Kai Wang To1,2, Kwok Yung Yuen1,2.
Abstract
This retrospective study of incoming travelers with coronavirus disease 2019 showed that individuals immunized by messenger RNA vaccines had significantly longer postvaccination intervals (median, 30.5 days) to breakthrough infection, lower white blood cell counts and lactate dehydrogenase levels on admission, and fewer radiographic abnormalities than those immunized by inactivated virus vaccine, who paradoxically had lower respiratory viral load.Entities:
Keywords: COVID-19; inactivated whole-virus vaccine; mRNA vaccine; vaccine breakthrough infection
Mesh：
Substances：
Year: 2022 PMID： 34984442 PMCID： PMC8755373 DOI： 10.1093/cid/ciab1062
Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 20.999